Caroline Chen is a healthcare reporter covering the drug industry and the intersection of health and technology. In the past year, she has written about innovations in gene editing and cancer immunotherapies, the challenge of pricing novel treatments, and co-authored a Bloomberg Businessweek cover story on blood-testing startup Theranos.